Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Do rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? – Data from the FNIH and IMI-APPROACH cohorts

Osteoarthritis and Cartilage(2025)10.1016/j.joca.2025.10.003Source: DataRank Database

Do rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? – Data from the FNIH and IMI-APPROACH cohorts is a research paper published in Osteoarthritis and Cartilage (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.00)OA: hybridTopics (41)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Mylène P. Jansen ORCID,S. Maschek,S.C. Mastbergen ORCID,A. Wisser ORCID,Harrie Weinans ORCID

Live enrichment

PubMed:41086901 OpenAlex:https://openalex.org/W4415092713

Innovative Medicines Initiative

Grant: 115770

Applied Public-Private Research enabling OsteoArthritis Clinical Headway

National Institutes of Health

Grant: N01-AR- 2\u20132258

National Institutes of Health

Grant: N01-AR-2\u20132261

National Institutes of Health

Grant: N01-AR-2\u20132259

National Institutes of Health

Grant: HHSN2682010000

National Institutes of Health

Grant: N01-AR-2\u20132260

National Institutes of Health

Grant: N01-AR-2\u20132262

Foundation for the National Institutes of Health

GlaxoSmithKline

Arthritis Foundation

FWCI

0.00

Citation Percentile

0.3%

hybridLicense: cc-by

journalhttps://www.oarsijournal.com/article/S1063-4584(25)01186-0/pdf

publisherhttps://www.oarsijournal.com/article/S1063-4584(25)01186-0/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1063458425011860?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1063458425011860?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.joca.2025.10.003

Fields of Study

Osteoarthritis Treatment and MechanismsLower Extremity Biomechanics and PathologiesTotal Knee Arthroplasty Outcomes03 medical and health sciences0302 clinical medicineHumansMaleCartilage, ArticularFemaleMiddle AgedOsteoarthritis, KneeMagnetic Resonance ImagingPatellofemoral JointSeverity of Illness IndexAgedKnee JointTibiaBone Marrow

MeSH Terms

AgedBone MarrowCartilage, ArticularFemaleHumansKnee JointMagnetic Resonance ImagingMaleMiddle AgedSeverity of Illness IndexTibiaOsteoarthritis, KneePatellofemoral Joint

Keywords

CartilageCartilage damageOsteoarthritisKnee cartilageArticular cartilage damageKneeMRIClinical TrialPatellofemoral JointOrdinal Scoring